1 year return (CAGR)
-24.48%
Bolt Biotherapeutics Exchange (NASDAQ, USD)
BOLT
3.98
+0.03 (+0.76%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
53.75%
5 year return (CAGR)
-26.54%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
7.67M
Price/Sales
1.63
Ent value
22.51M
Price/Book
0.61
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
56.41%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.83 |
| Daily high | 4.09 |
| Daily low | 3.70 |
| Daily Volume | 20K |
| All-time high | 39.93 |
| 1y analyst estimate | 29.00 |
| Beta | 1.08 |
| EPS (TTM) | -17.00 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BOLT | S&P500 | |
| Current price drop from All-time high | -90.03% | -2.19% |
| Highest price drop | -99.27% | -56.47% |
| Date of highest drop | 16 May 2025 | 9 Mar 2009 |
| Avg drop from high | -87.73% | -10.68% |
| Avg time to new high | 156 days | 12 days |
| Max time to new high | 1380 days | 1805 days |
News
